Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q8IU80: Variant p.Gly442Arg

Transmembrane protease serine 6
Gene: TMPRSS6
Feedback?
Variant information Variant position: help 442 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Glycine (G) to Arginine (R) at position 442 (G442R, p.Gly442Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In IRIDA; reduced HJV-mediated inhibition of HAMP transcription; reduced localization to the cell membrane; altered catalytic activity; autoproteolytic processing is reduced but it retains the ability to process HJV; able to interact with HJV. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 442 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 811 The length of the canonical sequence.
Location on the sequence: help IPVVATAGITINFTSQISLT G PGVRVHYGLYNQSDPCPGEF The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         IPVVATAGITINFTSQISLTGPGVRVHYGLYNQSDPCPGEF

Mouse                         IPMVASDGVTINFTSQISLTGPGVQVYYSLYNQSDPCPGEF

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 811 Transmembrane protease serine 6
Topological domain 77 – 811 Extracellular
Domain 335 – 452 CUB 2
Glycosylation 433 – 433 N-linked (GlcNAc...) asparagine
Glycosylation 453 – 453 N-linked (GlcNAc...) asparagine
Alternative sequence 409 – 461 LCGLRILQPYAERIPVVATAGITINFTSQISLTGPGVRVHYGLYNQSDPCPGE -> YHFLSSLWLPFLPPPPSLPSSTVTPSLEAQVPNLRGAARGASRGWGWCQACCP. In isoform 3.



Literature citations
Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia.
Silvestri L.; Guillem F.; Pagani A.; Nai A.; Oudin C.; Silva M.; Toutain F.; Kannengiesser C.; Beaumont C.; Camaschella C.; Grandchamp B.;
Blood 113:5605-5608(2009)
Cited for: INTERACTION WITH HJV; VARIANTS IRIDA ASN-521 AND LYS-522; CHARACTERIZATION OF VARIANTS IRIDA ARG-442; ASN-521 AND LYS-522; Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).
Finberg K.E.; Heeney M.M.; Campagna D.R.; Aydinok Y.; Pearson H.A.; Hartman K.R.; Mayo M.M.; Samuel S.M.; Strouse J.J.; Markianos K.; Andrews N.C.; Fleming M.D.;
Nat. Genet. 40:569-571(2008)
Cited for: VARIANTS IRIDA ARG-442; ASN-521 AND CYS-774; FUNCTION IN IRON HOMEOSTASIS; Functional analysis of Matriptase-2 mutations and domains: Insights into the molecular basis of iron refractory iron deficiency anemia.
McDonald C.J.; Ostini L.; Bennett N.C.; Subramaniam N.; Hooper J.; Velasco G.; Wallace D.F.; Subramaniam V.N.;
Am. J. Physiol. 308:C539-C547(2015)
Cited for: CHARACTERIZATION OF VARIANTS IRIDA CYS-141; THR-212; GLN-271; ARG-442 AND SER-510; SUBCELLULAR LOCATION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.